ACADIA Pharmaceuticals Inc. vs Equinor ASA — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.55 (market cap $5.07B), while Equinor ASA trades at $40.81 (market cap $97.58B). The key difference: Equinor ASA is far larger — about 19.2× ACADIA Pharmaceuticals Inc.'s market cap, and Equinor ASA pays a 3.81% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | EQNR | |
|---|---|---|
Market Cap | $5.07B | $97.58B |
Sector | Health | Energy |
52-Week High | $29.41 | $42.40 |
52-Week Low | $20.06 | $22.41 |
Enterprise Value | $4.19B | $106.28B |
Dividend Yield | — | 3.81% |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2021 (52% oil) and ended the year with 5.4 billion barrels of proven reserves (49% oil). Operations also include offshore wind, solar, oil refineries and natural gas processing, marketing, and trading.
Read more on EQNR →